The Safety of Newer Antidepressants in Pregnancy and Breastfeeding
- 1 January 2005
- journal article
- review article
- Published by Springer Nature in Drug Safety
- Vol. 28 (2) , 137-152
- https://doi.org/10.2165/00002018-200528020-00005
Abstract
The pregnancy and postpartum periods are considered to be relatively high risk times for depressive episodes in women, particularly for those with pre-existing psychiatric illnesses. Therefore, it...Keywords
This publication has 120 references indexed in Scilit:
- Paroxetine during breast-feeding: infant weight gain and maternal adherence to counselEuropean Journal of Pediatrics, 2004
- Mirtazapine: treatment of depression, anxiety, and hyperemesis gravidarum in the pregnant patient. A report of 7 casesArchives of Women's Mental Health, 2001
- Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitorsActa Paediatrica, 2001
- Excretion of citalopram in breast milkBritish Journal of Clinical Pharmacology, 1997
- Excretion of Fluoxetine and Its Metabolite, Norfluoxetine, in Human Breast MilkThe Journal of Clinical Pharmacology, 1996
- Tricyclic Drugs in Pregnancy and Lactation: A Preliminary ReportThe International Journal of Psychiatry in Medicine, 1991
- Infants of postpartum depressed mothers: Temperament and cognitive status.Journal of Abnormal Psychology, 1989
- Prevalence rates and demographic characteristics associated with depression in pregnancy and the postpartum.Journal of Consulting and Clinical Psychology, 1989
- Small left colon syndrome associated with maternal ingestion of psychotropic drugsThe Journal of Pediatrics, 1980
- Urinary retention in a neonate secondary to maternal ingestion of nortriptylineThe Journal of Pediatrics, 1972